Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats
- 1 April 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 234 (2-3) , 237-245
- https://doi.org/10.1016/0014-2999(93)90959-l
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproateEuropean Journal of Pharmacology, 1992
- Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone ratsEuropean Journal of Pharmacology, 1992
- Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systematic administrationEuropean Journal of Pharmacology, 1992
- Recent advances in the phencyclidine model of schizophreniaAmerican Journal of Psychiatry, 1991
- 6. Excitatory amino acid receptors in the human epileptogenic neocortexEpilepsy Research, 1991
- Anticonvulsant Activity of Two Orally Active Competitive N‐Methyl‐D‐Aspartate Antagonists, CGP 37849 and CGP 39551, Against Sound‐Induced Seizures in DBA/2 Mice and Photically Induced Myoclonus in Papio papioEpilepsia, 1991
- Potent oral anticonvulsant action of CPP and CPPene in DBA/2 miceEuropean Journal of Pharmacology, 1990
- Does kindling model anything clinically relevant?Biological Psychiatry, 1990
- Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novel N-methyl-D-aspartate antagonistEuropean Journal of Pharmacology, 1987
- Pharmacological modification of amygdaloid-kindled seizuresNeuropharmacology, 1980